Fact CheckerSign in

NCT06445725Completed

Acceptance Based Coping Skills for Diabetes Delivered By Promotores

Acceptance Based Coping (ABaCo) Skills Delivered By Promotores for Hispanic/Latino Patients With Type 2 Diabetes

Source: ClinicalTrials.gov · Last updated 26 Aug 2025

Brief summary (registry, in English)

The goal of this pilot clinical trial is to learn about the feasibility and acceptability of promotores (community health workers) delivering an educational intervention for Hispanic/Latino patients with type 2 diabetes. The main questions it aims to answer are: 1. What is the impact of the ABaCo program on participants' blood sugar management and quality of life? 2. How well are we able to enroll participants and keep them in the ABaCo program? 3. Is this telephone-based, educational ABaCo program acceptable? Participants will be asked to: * Participate in four research visits: provide fingerstick blood samples before and after the program (at 6 months), and complete questionnaires at four times times during the program (before, twice during, and at 6 months). * Participate in the ABaCo program: join seven (7) individual phone call visits with promotores to review educational information about caring for diabetes while keeping connected to life values. Each phone call lasts approximately 45 minutes once per week for six (6) weeks, then a refresher visit is a month later.

Status (registry)
Completed
Study type
Interventional
Enrollment
18 (actual)
First submitted
18 Apr 2024
Start date
4 Mar 2024
Primary completion date
24 Mar 2025
Lead sponsor
Baylor College of Medicine
NCT number
NCT06445725

What you commit to

  • Study type: Interventional
  • Participants enrolled: 18
  • From 4 Mar 2024 to the primary completion date, 24 Mar 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • A medical condition or life circumstance that would contraindicate participation

Other

  • Inability to read/comprehend the informed consent process or study instructions

Who the study is looking for

  • Age 18-70
  • Diagnosis of Type 2 Diabetes (T2DM)
  • HbA1c of 7.5% or greater (may be taking oral agents or injectables for T2DM management)
  • Evidence of avoidance coping (prescreen of \<48.4 on English or a \<52 on the Spanish Acceptance and Action Diabetes Questionnaire) and/or poor self-management skills (prescreen below recommended frequencies in 2 or more sub-scales of the Summary of Diabetes Self-Care Activities)
  • Self-identifies as Hispanic/Latino
  • Receiving ongoing care at study site clinic
  • Preferred language is English or Spanish

Age in the registry: 18 years to 70 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Texas Health Science Center at San Antonio
Coordinator of this site? Confirm its status
San AntonioUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.